NeuroPace (NPCE) Debt to Equity (2020 - 2026)
NeuroPace's quarterly Debt to Equity came in at $4.08 in Q1 2026, up 65.75% year-on-year from $2.46 in Q1 2025, and up 31.97% quarter-over-quarter from $3.09 in Q4 2025.
NeuroPace has reported Debt to Equity for 7 years, with the latest figure at $4.08 in Q1 2026.
- For the quarter ending Q1 2026, Debt to Equity rose 65.75% year-over-year to $4.08; the trailing twelve-month figure through Mar 2026 stood at $4.08 (up 65.75% YoY), and the FY2025 full-year result was $3.09, down 58.35% from the prior year.
- Debt to Equity for Q1 2026 stood at $4.08, up from $3.09 in the prior quarter.
- The five-year high for Debt to Equity was $7.43 in Q4 2024, with the low at $0.8 in Q1 2022.
- Average Debt to Equity over 5 years is $3.21, with a median of $3.02 recorded in 2025.
- Year-over-year, Debt to Equity surged 334.79% in 2022 and slumped 58.35% in 2025.
- Tracing NPCE's Debt to Equity over 5 years: stood at $1.52 in 2022, then surged by 81.24% to $2.76 in 2023, then jumped by 169.39% to $7.43 in 2024, then sank by 58.35% to $3.09 in 2025, then soared by 31.97% to $4.08 in 2026.
- The last three Debt to Equity figures came in at $4.08 (Q1 2026), $3.09 (Q4 2025), and $3.17 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | 4.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.08 |
| Dec 31, 2025 | 3.09 |
| Sep 30, 2025 | 3.17 |
| Jun 30, 2025 | 3.02 |
| Mar 31, 2025 | 2.46 |
| Dec 31, 2024 | 7.43 |
| Sep 30, 2024 | 6.03 |
| Jun 30, 2024 | 5.97 |
| Mar 31, 2024 | 4.05 |
| Dec 31, 2023 | 2.76 |
| Sep 30, 2023 | 3.42 |
| Jun 30, 2023 | 2.58 |
| Mar 31, 2023 | 1.96 |
| Dec 31, 2022 | 1.52 |
| Sep 30, 2022 | 1.20 |
| Jun 30, 2022 | 0.96 |
| Mar 31, 2022 | 0.80 |
| Dec 31, 2021 | 0.68 |
| Sep 30, 2021 | 0.61 |
| Jun 30, 2021 | 0.56 |
| Mar 31, 2021 | -0.34 |
| Dec 31, 2020 | -0.36 |